# Longitudinal Assessment of Genomic Alterations and Clonal Evolution in ALK-positive NSCLC (Galileo Project)

> **NCT06234579** · — · RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 108 (estimated)

## Conditions studied

- ALK Gene Mutation
- NSCLC Stage IV
- ALK Sensitizing Mutation

## Interventions

- **DIAGNOSTIC_TEST:** Biopsy (tissue or liquid)

## Key facts

- **NCT ID:** NCT06234579
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-12
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06234579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06234579, "Longitudinal Assessment of Genomic Alterations and Clonal Evolution in ALK-positive NSCLC (Galileo Project)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06234579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*